AI & Advanced Healthcare

Nicole Dale

Corpus Healthy Human Protein Atlas Gives AI a Better Map

Pharmatica image of a modern proteomics laboratory with analytical equipment representing the mapping of healthy human proteins for AI-driven drug discovery.

The healthy human protein atlas from Ambitious Bio could sharpen target safety checks in AI drug discovery. Explore the claims, the gaps, and the questions to ask.

How Sensor-Enhanced Patient Data Completes the Story of the Trial

Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, discusses sensor-enhanced patient data and wearable technology in clinical trials.

How much can clinical trials miss when researchers rely solely on patient-reported outcomes? Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, joins Trisha Pillay to discuss how wearable sensors complement electronic clinical outcome assessments (eCOA).

Nicole Dale

AI Breast Cancer Screening Moves From Trials to Policy

Pharmatica image of a bright radiology suite lit by natural light, with a soft blue imaging display and a glowing yellow highlight representing AI innovation in breast cancer screening.

AI breast cancer screening finds more cases and cuts radiologist workload, but recall risks remain. See what MASAI, AITIC, and EDITH mean for MedTech teams.

Nicole Dale

Target Atlas for Smarter Target Prioritisation for Parkinson’s

Pharmatica image of scientific papers, a glass slide, and laboratory glassware on a bright research desk, representing evidence review for Parkinson’s drug target prioritisation.

Target prioritisation gets an evidence upgrade. Find out how Phylo’s Target Atlas and the MJFF Parkinson’s edition rank disease drug targets.

Nicole Dale

The EU Biotech Act Puts Medical AI Safeguards at a Crossroads

Pharmatica image of a petri dish filled with blue liquid and ringed by twelve gold stars, with a single red drop sending ripples across the surface. It illustrates the EU Biotech Act and the debate over medical AI safeguards.

The EU Biotech Act aims to accelerate biotechnology development. Explore how proposed medical AI reforms could affect patient safety, compliance, and pharma competitiveness.

Nicole Dale

Clinical Trials in Depression Reveal New R&D Priorities in 2026

Pharmatica image representing clinical trials in depression, antidepressant development, patient data, and emerging CNS therapies.

Clinical trials in depression reveal a broader R&D landscape, from antidepressants and NMDA approaches to biological data and precision psychiatry.

Nicole Dale

OpenAI MentalHealthBench Tests AI in Mental Healthcare

OpenAI MentalHealthBench tests AI mental health replies with 80+ clinicians. See the scores, the risks, the trial evidence, and what HealthTech should do next.

Nicole Dale

AI Bioweapons Risk Grows as Agent Safeguards Fail

Pharmatica image showing an AI agent network integrated with molecular and pharmaceutical research elements to represent biosecurity and the AI bioweapons risk.

The AI bioweapons risk has entered a new, more worrying phase as Moonshot AI’s Kimi’s jailbreak exposes gaps in agent safeguards.

Nicole Dale

Dyson CameraJet Brings AI-Powered Precision to Oral Care

Pharmatica image showing an AI-powered toothbrush using computer vision to target oral care.

Find out how the Dyson CameraJet brings AI-powered oral care to everyday brushing, combining computer vision and precision fluid delivery for targeted care.

Nicole Dale

Inside Anthropic’s AI Biology Lab: A Pharma Reality Check

Pharmatica image of an AI-directed biology research environment connecting computational intelligence with a physical laboratory.

Anthropic has confirmed a physical AI biology lab in the Bay Area, alongside a hardware standard and verified model access for pharma and life sciences teams.

Nicole Dale

AlphaGenome Atlas: Mapping Every Possible DNA Variant

Pharmatica image representing the AlphaGenome Atlas genomic AI map with single-nucleotide variant prediction across the human genome.

Google DeepMind’s AlphaGenome Atlas maps all nine billion possible DNA variants, helping researchers rapidly prioritise disease-linked mutations.

Nicole Dale

Ketryx and Accenture Build Regulated AI MedTech at Scale

Pharmatica image of regulated AI connecting medical device software development, validation, traceability, and regulatory compliance.

Ketryx and Accenture are combining AI-native compliance infrastructure and transformation expertise to help MedTech scale regulated AI without slowing development.